ArticleTuberculosis and respiratory diseases2026
Redefining Acute Respiratory Distress Syndrome: A New Clinical Perspective.
Article in Tuberculosis and respiratory diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute respiratory distress syndrome (ARDS) continues to be a major cause of morbidity and mortality in critical care, yet its diagnosis and classification have historically been limited by varying resources and reliance on advanced technology. In 2024, a global redefinition of ARDS was introduced to overcome these challenges, constituting the most substantial update since the Berlin definition in 2012. This review summarizes the principal revisions to the criteria, including the formal adoption of lung ultrasound, SpO₂/FiO₂ ratios, and the explicit consideration of non-intubated ARDS and contexts with limited resources. These modifications are intended to promote more inclusive diagnostics, earlier detection, and improved research relevance. We provide a critical analysis of the advantages and drawbacks of the new definition, focusing on the heterogeneity of oxygenation measures, complications in FiO₂ assessment, and challenges in imaging evaluation. Additionally, the review underlines ongoing areas for refinement, comprising the establishment of uniform ventilator parameters, greater integration of carbon dioxide metrics, and the application of phenotypic stratification to support the advancement of precision medicine. This conceptual update signals a significant transformation in ARDS diagnosis and is expected to foster broader and more accessible critical care methodologies as well as expanded research participation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.